Category: New products
-
Patient Receives First Crispr Genetic Eye Treatment
An individual with a rare genetic eye disease received the first dose of an edited gene in a clinical trial of an experimental treatment for the disorder.
-
Wearable Defibrillator Maker Gains $145.6M
The developer of a patch device that monitors and adjusts heart rhythms to prevent sudden cardiac death is raising $145.6 million in a new venture funds.
-
Proteins from Bacteria Generate Power for Wearables
A collaboration of engineers and biologists created a way of producing electric power from humidity in the air with fine wires made of proteins from bacteria.
-
Foundation Supports ALS Inflammation Treatments
A foundation is funding a biotechnology company’s research on therapies to block proteins encouraging neuron inflammation in people with amyotrophic lateral sclerosis, or ALS.
-
Waste Plastic-to-Energy System Unveiled
A company developing waste-to-energy conversion systems revealed a version of its product that converts waste plastic to heat and electric power.
-
Infant Jumpsuit Captures Objective Movement Data
A one-piece garment fitted with sensors is shown to capture data about an infant’s movements for analysis by algorithms to reveal possible developmental problems.
-
Wireless Smart Bandage Designed for Chronic Wounds
A university lab developed a wirelessly-controlled programmable bandage that in tests with lab mice results in more diabetic wound closure than topical medicines.
-
Enrollment Completed in Aging Frailty Stem Cell Trial
A company developing stem cell treatments to counter frailty in older people finished enlisting participants in a clinical trial testing its therapies.
-
Engineered Bacteria Deliver Cancer Immunotherapy
13 Feb. 2020. A biomedical engineering team designed probiotic bacteria, which in lab mice are shown to deliver and enhance cancer immunotherapy drugs. Researchers at Columbia University in New York describe their engineered bacteria and findings in yesterday’s issue of the journal Science Translational Medicine (paid subscription required). Treatments that invoke the immune system to…
-
Synthetic Cell Matrix Devised for Cancer Drug Testing
A bioengineering lab is creating synthetic cell scaffolds that simulate tumor cells and tissue, offering a more reliable way of testing new cancer drugs.